PEDIATRICS Vol. 95 No. 5 May 1995, pp. 700-704
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Related articles in Pediatrics
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shah, B. R.
Right arrow Articles by Steiner, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shah, B. R.
Right arrow Articles by Steiner, P.

Acute Isoniazid Neurotoxicity in an Urban Hospital

Binita R. Shah MD1, Karen Santucci MD1, Richard Sinert DO2, and Phillip Steiner MD1

1 Children's Medical Center of Brooklyn, State University of New York, Health Science Center at Brooklyn
2 Department of Emergency Medicine, State University of New York, Health Science Center at Brooklyn

Objectives. To describe the presentation and treatment of acute isoniazid (INH) neurotoxicity appearing at an inner-city municipal hospital.

Design. Case series.

Participants. Seven patients (eight patient visits) with an age range of 5 days to 14.9 years.

Results. At our institution, no children appeared with acute INH neurotoxicity in the period 1985 through 1990, whereas seven patients were treated from 1991 through 1993. This paralleled the rise in the number of children with tuberculous infection and disease seen at our institution, from an average 96 per year to 213 per year during these two time periods. All seven patients were receiving INH daily for tuberculosis (TB) prophylaxis. Accidental ingestion (five episodes) and suicidal attempts (three episodes) accounted for these visits. The total amount ingested range from 14.3 to 99.3 mg/kg (mean, 54 mg/kg). All but one patient presented with afebrile seizures. One patient presented twice with seizures. Acute INH neurotoxicity was not suspected on the first admission; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute INH neurotoxicity was made.

Intervention. Intravenous pyridoxine was used in five episodes. Because it was not a stocked item in our pediatric emergency cart (as well as at another hospital, necessitating a transfer of a patient with refractory seizures to our hospital), the average delay was 5.8 hours (range, 1.3 to 13 hours) before it was given. Two patients with refractory seizures failed to respond to anticonvulsants, and their seizures were controlled only after parenteral pyridoxine.

Conclusions. We have seen an increased incidence of acute INH neurotoxicity because of the resurgence of TB in New York City. Others as well may see a similar rise based on local trends in TB infection and disease. Acute INH toxicity should be suspected in children presenting with seizures with or without fever. In patients with a known access to INH, seizures should be considered to be caused by INH toxicity unless proved otherwise. Parenteral pyridoxine, the specific antidote for INH-induced refractory seizures, should be readily available in every emergency department in the areas similarly experiencing increasing trends of TB.

Submitted on May 31, 1994
Accepted on August 17, 1994


Related articles in Pediatrics:

Acute Isoniazid Neurotoxicity in an Urban Hospital
Binita R. Shah, Karen Santucci, Richard Sinert, and Phillip Steiner
Pediatrics 1995 95: 703. [Abstract]  



This article has been cited by other articles:


Home page
Toxicol Ind HealthHome page
H. Yilmaz, E Uz, O Gokalp, N Ozcelik, E Cicek, and M. Ozer
Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats
Toxicology and Industrial Health, September 1, 2008; 24(8): 519 - 524.
[Abstract] [PDF]


Home page
J Child NeurolHome page
H. Caksen, D. Odabas, M. Erol, O. Anlar, O. Tuncer, and B. Atas
Do Not Overlook Acute Isoniazid Poisoning in Children With Status Epilepticus
J Child Neurol, February 1, 2003; 18(2): 142 - 143.
[Abstract] [PDF]


Home page
NEJMHome page
C. B. Groba, R. M. Walls, M. J. Sagarin, L. S. Nelson, J. Rella, R. S. Hoffman, B. J. Traynor, O. Hardiman, D. H. Lowenstein, and B. K. Alldredge
Status Epilepticus
N. Engl. J. Med., August 6, 1998; 339(6): 409 - 410.
[Full Text]


Home page
JWatch GeneralHome page
ISONIAZID NEUROTOXICITY
Journal Watch (General), May 16, 1995; 1995(516): 3 - 3.
[Full Text]